Delivery Order SPE2DB24D9803-SPE2DB24FJRYF
Award Date
9/23/24
Potential Completion Date
10/15/24
Potential Value
$2.1K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order with a ceiling value of $4,288.14. The contract is for the supply of Nexplanon 68 mg implants, a contraceptive product, to the Defense Logistics Agency (DLA) under the Medical Supply Chain division. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the delivery of Nexplanon 68 mg implants. The contract has a ceiling value of $8,576.28 and a period of performance through December 2, 2024. DMS Pharmaceutical Group holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued up to $499,999,999 and valid through November...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is for the delivery of Nexplanon 68 mg contraceptive implants to the Defense Logistics Agency's (DLA) Medical Supply Chain division. The $5,717.52 firm fixed-price delivery order falls under a larger $499,999,999 indefinite delivery contract (IDC) with the DLA, which allows the agency to issue orders for a comprehensive range of pharmaceutical products to support the medical supply needs of Department...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,144.07, is for the delivery of 68 mg Nexplanon implants. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, which runs through December 31, 2025. The IDC allows the DLA to issue firm fixed-price...
This contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,576.28 firm fixed-price delivery order is for 68 mg Nexplanon contraceptive implants. The order was placed under DMS Pharmaceutical Group's existing $499,999,999 indefinite delivery contract (IDC) with the DLA, which runs through December 31, 2025. This single-award IDC vehicle allows the DLA to issue...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is for the delivery of 68 mg Nexplanon implants. The $14,293.80 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) under the Medical Supply Chain division, which distributes pharmaceuticals and medical supplies to Department of Defense (DoD) healthcare facilities. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with...
This is a federal contract award from the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, a $2,144.07 firm fixed-price delivery order, is for the purchase of 68 mg Nexplanon contraceptive implants. The contract has no set-aside designation and is part of a larger $499,999,999 indefinite delivery contract (IDC) with DMS Pharmaceutical Group that allows DLA to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $3,573.45, is for the supply of Nexplanon 68 mg implants, a type of contraceptive device. This award is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. The...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,288.14 firm fixed-price contract is for the supply of Nexplanon 68 mg implants to support the medical needs of the Department of Defense. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA. The IDC...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide Nexplanon 68 mg implants. The contract, valued at $2,858.76, has an ultimate completion date of August 1, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, which runs through December 31, 2025. The IDC allows the DLA to issue firm-fixed-price...